Indication
For the short-term treatment of postoperative pain in adults.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Pain, Postoperative
Marketing Authorisation Holder: Pfizer Europe MA EEIG
EMA Authorisation: 22/03/2002
INN: parecoxib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Dynastat: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.